Lee M. Nadler

CD40-Activated B-Cells as Antigenpresenting Cells: From Immunobiology to Immunotherapy

antileukemic immune responses lymphoblastic leukemia and acute myeloid leukemia cells to induce colony-stimulating factor in human acute - granulocyte-macrophage Lentiviral vectors for efficient delivery of CD80 and

lymphoblastic leukemia cells by down-regulating the cyclin-dependent kinase Interleukin-7 promotes survival and cell cycle progression of T-cell acute

T-cell chemotaxis: potential as cellular adjuvants CD40-activated B-cells express full 'lymph node homing triad' and induce

cells and preferential enrichment for antigen specificity Engagement of CD83 ligand induces prolonged expansion of CD8+ T

antigen-presenting cells: potential for clinical application efficiently induced by means of CD40-activated B cells as Human primary and memory cytotoxic T lymphocyte responses are

by specific cytotoxic T cells The shared tumor-associated antigen cytochrome P450 1B1 is recognized

antileukemic immune responses lymphoblastic leukemia and acute myeloid leukemia cells to induce granulocyte-macrophage- colony-stimulating factor in human acute Lentiviral vectors for efficient delivery of CD80 and

and is inhibited by simultaneous blockade of mTOR and NF-{kappa}B Proangiogenic stimulation of bone marrow endothelium engages mTOR

myelomonocytic leukemia {gamma}-globin, a putative tumor-associated antigen for juvenile Identification of an immunogenic CD8+ T cell epitope derived from